Mycosis fungoides is a type of cutaneous T-cell lymphoma, a cancer caused by abnormal proliferation of a type of white blood cells called T lymphocytes or T-cells and their infiltration into the skin.
This page lists all known medications that could potentially lead to 'Mycosis fungoides' as a side effect. It's important to note that mild side effects are quite common with medications. The ...
Please provide your email address to receive an email when new articles are posted on . Topical synthetic hypericin ointment, activated with visible light, shows efficacy in reducing mycosis fungoides ...
Cutaneous T cell lymphomas (CTCL) represent a heterogeneous group of T-cell malignancies that manifest primarily in the skin. By far the most common variant of CTCL is mycosis fungoides and its ...
Objective: Three patients with follicular mycosis fungoides (FMF), a rare variant of folliculotropic cutaneous T-cell lymphoma, are discussed. Follicular involvement in cutaneous T-cell lymphoma ...
In this study, we identify recurrent alterations in the TNFR2 pathway in addition to other genes regulating T cell survival and proliferation that affect more than a third of patients with mycosis ...
Hypopigmented mycosis fungoides is an uncommon clinical variant of cutaneous T-cell lymphoma. We hypothesized that hypomelanosis in hypopigmented mycosis fungoides may have a similar mechanism as in ...
Please provide your email address to receive an email when new articles are posted on . A post-hoc analysis of a key data set for chlormethine in mycosis fungoides showed that the gel formulation of ...
Lacutamab is a first-in-class anti-KIR3DL2 humanized cytotoxicity-inducing antibody that is currently in clinical trials for treatment of cutaneous T-cell lymphoma (CTCL), an orphan disease, and ...
In the last few years, there have been scattered reports linking dupilumab with mycosis fungoides. A recent study from the Journal of the American Academy of Dermatology reported a systematic review ...
DelveInsight's Mycosis Fungoides Market Insights report includes a comprehensive understanding of current treatment practices, mycosis fungoides emerging drugs, market share of individual therapies, ...
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Mycosis Fungoides Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results